| Biologic Therapy |
1 |
1 |
| Noncolorectal Gastrointestinal Cancer |
0 |
0.96 |
| Antineoplastic Drug |
0 |
0.85 |
| Gastric Cancer |
0 |
0.98 |
| Cancer |
0 |
0.66 |
| Humanized Monoclonal Antibody |
0 |
0.38 |
| Chemotherapy |
0 |
0.99 |
| Tumor |
0 |
0.28 |
| Platinum |
0 |
0.19 |
| Biomarker |
0 |
0.1 |
| Clinical Research |
0 |
0.95 |
| T-Lymphocyte |
0 |
0.1 |
| Adenocarcinoma of the Gastroesophageal Junction |
0 |
0.94 |
| Adenocarcinoma |
0 |
0.05 |
| Board Certification |
0 |
0.05 |
| Food and Drug Administration (FDA) |
0 |
0.05 |
| Immunotherapy |
0 |
0.9 |
| New York |
0 |
0.05 |
| Stomach |
0 |
0.05 |